Greece - Re-Imbursed Pharmaceutical Market
Since 2014, Greece Re-Imbursed Pharmaceutical Market grew 5.9points year on year. At 25.3 Percent of Generics in Value in 2019, the country was ranked number 7 among other countries in Re-Imbursed Pharmaceutical Market. Greece is overtaken by Canada, which was ranked number 6 at 26.8 Percent of Generics in Value and is followed by Slovakia with 25.2 Percent of Generics in Value. Austria topped the ranking with 52.2 Percent of Generics in Value in 2019, that is a growth of 2.8points versus 2018. United Kingdom, Turkey and New Zealand respectively ranked number 2, 3 and 4 in this ranking. Denmark recorded the best 5 years average growth at +6.9points per year, while Slovakia recorded the worst performance at -7.8points per year.
Loading...
| Date | Percent of Generics in Value |
|---|---|
| 2019 | 25.30 |
| 2018 | 22.60 |
| 2017 | 21.40 |
| 2016 | |
| 2015 | 22.60 |
How does Greece rank in Re-Imbursed Pharmaceutical Market?
| # | 17 Countries | Percent of Generics in Value | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Austria
|
52.20 % | 2019 | +2.8 % | +2.2 % | View data | |
| 2 |
#2
United Kingdom
|
38.50 % | 2019 | +2.1 % | +2.6 % | View data | |
| 6 |
#6
Canada
|
26.80 % | 2019 | -2.9 % | -4.1 % | View data | |
| 7 |
#7
Greece
|
25.30 % | 2019 | +11.9 % | +5.9 % | View data | |
| 8 |
#8
Slovakia
|
25.20 % | 2019 | -4.2 % | -7.8 % | View data | |